Chronic Kidney Disease in Type 2 Diabetes: Optimizing Glucose-Lowering Therapy

被引：0
|
作者：
Bakris, George [1 ]
机构：
[1] Univ Chicago Med, AHA Comprehens Hypertens Ctr, Med, Chicago, IL 60637 USA
来源：
JOURNAL OF FAMILY PRACTICE | 2019年 / 68卷 / 08期
关键词：
ASSOCIATION TASK-FORCE; AMERICAN-COLLEGE; MANAGEMENT; LIRAGLUTIDE; GUIDELINE; MORTALITY; OUTCOMES; ADULTS;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S1 / S6
页数：6
相关论文
共 50 条
  • [1] Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease
    SHamkhalova, M. S. H.
    YArek-Martynova, I. Y. A.
    Trubitsyna, N. P.
    SHestakova, M., V
    DIABETES MELLITUS, 2013, 16 (03): : 97 - 102
  • [2] Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease
    Inzucchi, Silvio E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 137 - +
  • [3] Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
    Lo, Clement
    Toyama, Tadashi
    Wang, Ying
    Lin, Jin
    Hirakawa, Yoichiro
    Jun, Min
    Cass, Alan
    Hawley, Carmel M.
    Pilmore, Helen
    Badve, Sunil V.
    Perkovic, Vlado
    Zoungas, Sophia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (09):
  • [4] Glucose-lowering medicines for type 2 diabetes
    Davoren, Peter
    AUSTRALIAN FAMILY PHYSICIAN, 2015, 44 (05) : 272 - 276
  • [5] Effectiveness of glucose-lowering therapy in type 2 diabetes in primary care
    Jacobs, Esther
    Kostev, Karel
    Rathmann, Wolfgang
    DIABETOLOGE, 2019, 15 (02): : 89 - 95
  • [6] Initial glucose-lowering therapy and cardiovascular outcomes in type 2 diabetes
    Misnikova, I. V.
    Dreval, A. V.
    Kovaleva, Y. A.
    DIABETOLOGIA, 2012, 55 : S326 - S326
  • [7] Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
    Ferrannini, Ele
    DeFronzo, Ralph A.
    EUROPEAN HEART JOURNAL, 2015, 36 (34) : 2288 - U19
  • [8] Expert consensus on personalized initiation of glucose-lowering therapy in adults with newly diagnosed type 2 diabetes without clinical cardiovascular disease or chronic kidney disease
    Zhang, Fang
    Ji, Linong
    Hong, Tianpei
    Guo, Lixin
    Li, Yan
    Zhu, Zhiming
    Liu, Xingbin
    Liu, Fang
    Tang, Lizhi
    Zhang, Yuwei
    Li, Juan
    Lu, Qingguo
    Tong, Nanwei
    JOURNAL OF EVIDENCE BASED MEDICINE, 2022, 15 (02) : 168 - 179
  • [9] Glucose-lowering effects of sulfasalazine in type 2 diabetes
    Haas, RM
    Li, P
    Chu, JW
    DIABETES CARE, 2005, 28 (09) : 2238 - 2239
  • [10] Future glucose-lowering drugs for type 2 diabetes
    Bailey, Clifford J.
    Tahrani, Abd A.
    Barnett, Anthony H.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (04): : 350 - 359
12345